Added to YB: 2017-09-01
Pitch date: 2017-09-01
FOLD:US [bullish]
Amicus Therapeutics, Inc.
-27.39%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.
Market Cap
$2.9B
Pitch Price
$14.53
Price Target
N/A
Dividend
N/A
EV/EBITDA
63.35
P/E
-207.42
EV/Sales
5.18
Sector
Biotechnology
Category
N/A
Show full summary:
Amicus Therapeutics Inc FOLD:US
A summary for this pitch has not been created yet.
Read full article (0 min)